FDA warning

The U.S. Food and Drug Administration has recently issued a stern warning to the public, advising against the purchase and use of multiple specific over-the-counter eye drop products from prominent brands.  The agency has raised concerns about the potential risk of eye...

Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) announced the U.S. Food and Drug Administration (FDA) has refused to accept the company’s Biologics License Application (BLA) with a Refusal to File (RTF) letter. The company filed the BLA in April for its lead drug candidate pegzilarginase for...

Stock futures pointed to a lower open following premarket data revealing that the U.S. economy and job market are improving faster and stronger than expected. Selling began at the bell and continued for the entire day as major indices failed to hold on to any rallying gains. Investors and...